Sponsor:
National Cancer Institute (NCI)
Code:
NCT05691465
Conditions
Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation
Metastatic Prostate Neuroendocrine Carcinoma
Metastatic Prostate Small Cell Neuroendocrine Carcinoma
Stage IV Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Gallium Ga 68-DOTATATE
Lutetium Lu 177 Dotatate
Positron Emission Tomography
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-22. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-04-17.